Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital /ID# 160158

Sapporo, Hokkaido 060-0033

0 studies enrolling now · 1 studies all time

What they study most

Crohn's Disease

Studies at this site

• A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease — Completed